Our results indicate that S100B transcript upregulation is solely present in low-nSOD1 PBMCs, and thus, it might exert its toxic activity on cell survival and aggravate the ALS pathology exclusively in this subgroup. The gene discussed is S100B; the disease is amyotrophic lateral sclerosis.